policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Foot and mouth disease
Foot-and-mouth disease (FMD) is a severe, highly contagious viral disease of worldwide concern. View AVMA's recommendations for FMD preparedness and…
AVMA news
Conference of Research Workers in Animal Diseases – January 20-24, 2023
The Conference of Research Workers in Animal Diseases (CRWAD) held its annual conference from January 20-24 in Chicago. The CRWAD presented awards,…
AVMA news
K-State funded for new African swine fever studies
Kansas State University researchers will conduct a $500,000-plus research project to examine how African swine fever virus survives and spreads on…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
National Academies of Practice adds new veterinary fellows
The new veterinary fellows in the National Academies of Practice are Drs. Ellen N. Behrend, Sherry Burrer, Ruthanne Chun, Patricia Sanchez Diaz, Laura…